SKAN.SW SKAN Group AG (SIX) pre-market 19 Mar 2026: Earnings 24 Mar, margin drivers key

Earnings are due on 24 Mar 2026, and SKAN.SW stock opens pre-market on 19 Mar 2026 at CHF 46.20. We expect the SKAN Group AG (SIX) report to focus on margin trends and services demand. Traders should watch orders, Services & Consumables growth, and guidance for 2026. Our preview connects fundamentals, valuation, and the technical setup ahead of the release.

SKAN.SW stock: Earnings calendar and what to expect

SKAN Group AG (SKAN.SW) reports on 24 Mar 2026 after market hours. Consensus details are thin, so management commentary will matter. Key metrics to watch are revenue growth in Services & Consumables, EBIT margin, and recurring-service bookings. Expect questions on supply-chain lead times and order backlog that can change short-term earnings visibility.

SKAN.SW stock: Recent price action and valuation

SKAN.SW closed pre-market near CHF 46.20, down 1.39% on the day from CHF 46.85. The stock trades below its 50-day average of CHF 54.12 and 200-day average of CHF 58.47. Market cap is CHF 1.04B and P/E is 64.17 on EPS 0.72, well above the healthcare sector average P/E 28.90, signalling rich valuation if growth slows.

SKAN.SW stock: Financials, margins and cash flow signals

Trailing metrics show revenue per share CHF 14.77 and free cash flow per share CHF 0.82. Gross margin sits near 72.53% and net margin near 4.87%. Current ratio is 1.15 and debt to equity is 0.06, indicating low leverage. Watch capex-to-revenue at 0.15 and the payout ratio of 0.56 for dividend sustainability.

SKAN.SW stock: Technical setup and trading cues

Technicals look oversold: RSI 30.91 and Williams %R -96.92. Bollinger lower band is CHF 45.96 and ATR is CHF 2.02, signalling elevated near-term volatility. Volume at 14,612 is below average 32,853, so moves may lack conviction until earnings. Short-term support sits CHF 46.00 and resistance near CHF 50.20.

SKAN.SW stock: Meyka AI grade and forecast

Meyka AI rates SKAN.SW with a score of 72.83 out of 100: B+ (BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month target of CHF 45.66, implying a -1.15% downside versus current price CHF 46.20. Forecasts are model-based projections and not guarantees.

SKAN.SW stock: Risks, catalysts and sector context

Primary risks are margin compression, slower equipment orders, and extended inventory cycles (days of inventory 447.76). Catalysts include renewed service contracts, digital product rollouts, and better-than-expected guidance. Compared to the healthcare sector, SKAN shows strong gross margins but a higher valuation, increasing sensitivity to earnings misses.

Final Thoughts

SKAN.SW stock enters earnings season with mixed signals. The company posts strong gross margins and low leverage, but valuation is stretched with a P/E of 64.17 and shares below their 50- and 200-day averages. Technicals show oversold readings, which can magnify post-report moves. Meyka AI’s forecast of CHF 45.66 implies a small downside of -1.15% to the current CHF 46.20 price, underscoring that upside will require clear margin or order improvements. We note the next catalyst is the 24 Mar 2026 earnings release and advise watching guidance and recurring-service growth. Meyka AI provides this as an AI-powered market analysis platform; forecasts and grades are model outputs, not guarantees or investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.